Opendata, web and dolomites


Defining functional networks of genetic causes for ALS and related neurodegenerative disorders

Total Cost €


EC-Contrib. €






 ALS-Networks project word cloud

Explore the words cloud of the ALS-Networks project. It provides you a very rough idea of what is the project "ALS-Networks" about.

degradation    expand    power    fatal    43    relevance    samples    neurological    markers    tdp    regulation    extend    demonstrated    representing    contributed    neurodegeneration    caused    zebrafish    rna    genomic    diseases    lines    therapeutic    sqstm1    prevalent    network    cascades    genetic    pathophysiological    autophagy    causing    outcome    proposing    expression    pinpoint    discovery    content    indicates    38    screens    variants    c9orf72    model    phenotype    800    genetically    underlie    editing    bioactive    models    multiple    patient    stress    invariably    vertebrate    disease    innovative    strategies    uncover    health    groundbreaking    neuroprotective    tools    mechanisms    knockout    permit    mutations    functional    compounds    granule    molecular    neuron    fus    screened    effect    simultaneous    als    validating    converging    population    pathogenic    interactors    spinal    billion    combine    transgenic    amenable    cord    alleles    modifiers    death    causative    gene    interactions    neurodegenerative    genes    cellular    amongst    animal    interact    fundamental    pharmacological    brain    first    pathological    functionally    mutant    motor    annually    function    interaction    disorders   

Project "ALS-Networks" data sheet

The following table provides information about the project.


Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 2˙000˙000 €
 EC max contribution 2˙000˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2015-CoG
 Funding Scheme ERC-COG
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2022-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Brain and spinal cord diseases affect 38% of the European population and cost over 800 billion € annually; representing by far the largest health challenge. ALS is a prevalent neurological disease caused by motor neuron death with an invariably fatal outcome. I contributed to ALS research with the groundbreaking discovery of TDP-43 mutations, functionally characterized these mutations in the first vertebrate model and demonstrated a genetic interaction with another major ALS gene FUS. Emerging evidence indicates that four major causative factors in ALS, C9orf72, TDP-43, FUS & SQSTM1, genetically interact and could function in common cellular mechanisms. Here, I will develop zebrafish transgenic lines for all four genes, using state of the art genomic editing tools to combine simultaneous gene knockout and expression of the mutant alleles. Using these innovative disease models I will study the functional interactions amongst these four genes and their converging effect on key ALS pathogenic mechanisms: autophagy degradation, stress granule formation and RNA regulation. These studies will permit to pinpoint the molecular cascades that underlie ALS-related neurodegeneration. We will further expand the current ALS network by proposing and validating novel genetic interactors, which will be further screened for disease-causing variants and as pathological markers in patient samples. The power of zebrafish as a vertebrate model amenable to high-content phenotype-based screens will enable discovery of bioactive compounds that are neuroprotective in multiple animal models of disease. This project will increase the fundamental understanding of the relevance of C9orf72, TDP-43, FUS and SQSTM1 by developing animal models to characterize common pathophysiological mechanisms. Furthermore, I will uncover novel genetic, disease-related and pharmacological modifiers to extend the ALS network that will facilitate development of therapeutic strategies for neurodegenerative disorders


year authors and title journal last update
List of publications.
2018 Hortense de Calbiac, Adriana Dabacan, Elise Marsan, Hervé Tostivint, Gabrielle Devienne, Saeko Ishida, Eric Leguern, Stéphanie Baulac, Raul C. Muresan, Edor Kabashi, Sorana Ciura
Depdc5 knockdown causes mTOR-dependent motor hyperactivity in zebrafish
published pages: 510-523, ISSN: 2328-9503, DOI: 10.1002/acn3.542
Annals of Clinical and Translational Neurology 5/5 2019-05-14
2017 Shunmoogum A. Patten, Dina Aggad, Jose Martinez, Elsa Tremblay, Janet Petrillo, Gary A.B. Armstrong, Alexandre La Fontaine, Claudia Maios, Meijiang Liao, Sorana Ciura, Xiao-Yan Wen, Victor Rafuse, Justin Ichida, Lorne Zinman, Jean-Pierre Julien, Edor Kabashi, Richard Robitaille, Lawrence Korngut, J. Alexander Parker, Pierre Drapeau
Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis
published pages: , ISSN: 2379-3708, DOI: 10.1172/jci.insight.97152
JCI Insight 2/22 2019-05-14

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALS-NETWORKS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALS-NETWORKS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ChaperoneRegulome (2020)

ChaperoneRegulome: Understanding cell-type-specificity of chaperone regulation

Read More  

EffectiveTG (2018)

Effective Methods in Tame Geometry and Applications in Arithmetic and Dynamics

Read More  

PSYDISC (2020)

Developing and Testing the Psychological Distance to Science Model

Read More